Side Chain Modifications Change the Binding and Agonist Properties of Endomorphin 2
- 1 January 2002
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 290 (1) , 153-161
- https://doi.org/10.1006/bbrc.2001.6136
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Differential antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexoneBrain Research, 2000
- μ Opioid receptor: role for the amino terminus as a determinant of ligand binding affinityMolecular Brain Research, 2000
- Specific activation of the μ opioid receptor (MOR) by endomorphin 1 and endomorphin 2European Journal of Neuroscience, 2000
- Endogenous opiates: 1998☆Peptides, 1999
- Pain Inhibition by EndomorphinsAnnals of the New York Academy of Sciences, 1999
- The μ-opioid receptor gene-dose dependent reductions in G-protein activation in the pons/medulla and antinociception induced by endomorphins in μ-opioid receptor knockout miceNeuroscience, 1999
- Membrane Microviscosity Modulates μ‐Opioid Receptor Conformational Transitions and Agonist EfficacyJournal of Neurochemistry, 1999
- In VitroBinding and Signaling Profile of the Novel μ Opioid Receptor Agonist Endomorphin 2 in Rat Brain MembranesBiochemical and Biophysical Research Communications, 1998
- A potent and selective endogenous agonist for the µ-opiate receptorNature, 1997
- Go mediates the coupling of the mu opioid receptor to adenylyl cyclase in cloned neural cells and brain.Proceedings of the National Academy of Sciences, 1993